Information on the Bristol-Myers Squibb and Celgene Transaction
Learn more about Bristol-Myers Squibb’s planned acquisition of Celgene.
Intended for U.S. scientific audiences only.
Bristol-Myers Squibb at #EULAR 2019
Investigating personalized approaches and addressing unmet patient needs at The European Congress of Rheumatology.
News & Perspectives
2018 Annual Report
In every part of our organization and across the world, we are focused on the future. We are ready to provide patients with even more treatment options and even more hope. They are the reason we work harder and faster to deliver results.
Looking for Answers?
Quick links to helpful resources.